Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | PDK1 | Q15118 | 2/20 | 0.36 |
| ▸ | WHR1 | P49842 | 1/20 | 0.34 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.34 |
| ▸ | PDE5A | O76074 | 2/20 | 0.33 |
| ▸ | KDM1A | O60341 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24255626 | 0.96 | MEN1 (0.44) | MEN1KMT2AATMPDK1WHR1 | |
| SCHEMBL24255643 | 0.94 | MEN1 (0.41) | MEN1KMT2AATMPDK1WHR1 | |
| SCHEMBL26415640 | 0.90 | MEN1 (0.37) | MEN1KMT2AATMPDK1WHR1 | |
| SCHEMBL24255610 | 0.90 | MEN1 (0.39) | MEN1KMT2AATMPDK1WHR1 | |
| SCHEMBL25975623 | 0.90 | MEN1 (0.40) | MEN1KMT2AATMPDK1WHR1 | |
| SCHEMBL24255661 | 0.88 | MAPT (0.33) | MEN1KMT2AATMABCG2PDE5A | |
| SCHEMBL24255936 | 0.87 | MEN1 (0.49) | MEN1KMT2AATMPDK1WHR1 | |
| SCHEMBL25979950 | 0.87 | MEN1 (0.48) | MEN1KMT2AATMPDK1WHR1 | |
| SCHEMBL26420590 | 0.87 | MAPT (0.33) | MEN1KMT2AATMKDM1AKDM4E | |
| SCHEMBL26415489 | 0.86 | MEN1 (0.37) | MEN1KMT2AATMPDK1WHR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230337529-A1 | ORGANIC LIGHT-EMITTING DEVICE AND COMPOSITION FOR FORMING ORGANIC MATERIAL LAYER | LT MATERIALS CO., LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
| US-20230337529-A1 | ORGANIC LIGHT-EMITTING DEVICE AND COMPOSITION FOR FORMING ORGANIC MATERIAL LAYER | LT MATERIALS CO., LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
| US-20230320211-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE | LT MATERIALS CO., LTD. (KR) | 2023-10-05 | — | — | US | disclosed |
| US-20230320211-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE | LT MATERIALS CO., LTD. (KR) | 2023-10-05 | — | — | US | disclosed |
| WO-2022035097-A1 | ORGANIC LIGHT-EMITTING DEVICE AND COMPOSITION FOR FORMING ORGANIC MATERIAL LAYER | 엘티소재주식회사 | 2022-02-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230320211-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE | ORC3, CRY1, SUN2 | MEN1 1044/4885KMT2A 1149/4885ATM 1824/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.